AXL CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting AXL, serving as an excellent tool for exploring novel CAR-T cell immunotherapies against AXL-expressing malignancies, facilitating research into targeted immune recognition and overcoming resistance mechanisms. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of AXL CAR mRNA-LNP include evaluating CAR expression on engineered T cells and assessing their cytotoxic activity against AXL-positive cancer cell lines. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.
.png)